Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 1
2006 1
2007 2
2008 2
2009 5
2010 4
2011 1
2012 3
2013 1
2014 2
2015 1
2016 5
2017 4
2018 3
2019 6
2020 9
2021 6
2022 6
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer.
Di Modugno F, Di Carlo A, Spada S, Palermo B, D'Ambrosio L, D'Andrea D, Morello G, Belmonte B, Sperduti I, Balzano V, Gallo E, Melchionna R, Panetta M, Campo G, De Nicola F, Goeman F, Antoniani B, Carpano S, Frigè G, Warren S, Gallina F, Lambrechts D, Xiong J, Vincent BG, Wheeler N, Bortone DS, Cappuzzo F, Facciolo F, Tripodo C, Visca P, Nisticò P. Di Modugno F, et al. Among authors: nistico p. EBioMedicine. 2024 Mar;101:105003. doi: 10.1016/j.ebiom.2024.105003. Epub 2024 Feb 9. EBioMedicine. 2024. PMID: 38340557 Free PMC article.
Integrating AI-Powered Digital Pathology and Imaging Mass Cytometry Identifies Key Classifiers of Tumor Cells, Stroma, and Immune Cells in Non-Small Cell Lung Cancer.
Rigamonti A, Viatore M, Polidori R, Rahal D, Erreni M, Fumagalli MR, Zanini D, Doni A, Putignano AR, Bossi P, Voulaz E, Alloisio M, Rossi S, Zucali PA, Santoro A, Balzano V, Nisticò P, Feuerhake F, Mantovani A, Locati M, Marchesi F. Rigamonti A, et al. Among authors: nistico p. Cancer Res. 2024 Apr 1;84(7):1165-1177. doi: 10.1158/0008-5472.CAN-23-1698. Cancer Res. 2024. PMID: 38315789 Free PMC article.
Transcription factors in fibroblast plasticity and CAF heterogeneity.
Melchionna R, Trono P, Di Carlo A, Di Modugno F, Nisticò P. Melchionna R, et al. Among authors: nistico p. J Exp Clin Cancer Res. 2023 Dec 20;42(1):347. doi: 10.1186/s13046-023-02934-4. J Exp Clin Cancer Res. 2023. PMID: 38124183 Free PMC article. Review.
CD28/PD1 co-expression: dual impact on CD8+ T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients' survival and ICB response.
Palermo B, Franzese O, Frisullo G, D'Ambrosio L, Panetta M, Campo G, D'Andrea D, Sperduti I, De Nicola F, Goeman F, Gallina F, Visca P, Facciolo F, Nisticò P. Palermo B, et al. Among authors: nistico p. J Exp Clin Cancer Res. 2023 Oct 28;42(1):287. doi: 10.1186/s13046-023-02846-3. J Exp Clin Cancer Res. 2023. PMID: 37898752 Free PMC article.
Machine learning endometrial cancer risk prediction model: integrating guidelines of European Society for Medical Oncology with the tumor immune framework.
Bruno V, Betti M, D'Ambrosio L, Massacci A, Chiofalo B, Pietropolli A, Piaggio G, Ciliberto G, Nisticò P, Pallocca M, Buda A, Vizza E. Bruno V, et al. Among authors: nistico p. Int J Gynecol Cancer. 2023 Nov 6;33(11):1708-1714. doi: 10.1136/ijgc-2023-004671. Int J Gynecol Cancer. 2023. PMID: 37875322 Free PMC article.
Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials.
Marinelli D, Gallina FT, Pannunzio S, Di Civita MA, Torchia A, Giusti R, Gelibter AJ, Roberto M, Verrico M, Melis E, Tajè R, Cecere FL, Landi L, Nisticò P, Porciello N, Occhipinti M, Brambilla M, Forde PM, Liu SV, Botticelli A, Novello S, Ciliberto G, Cortesi E, Facciolo F, Cappuzzo F, Santini D. Marinelli D, et al. Among authors: nistico p. Crit Rev Oncol Hematol. 2023 Dec;192:104190. doi: 10.1016/j.critrevonc.2023.104190. Epub 2023 Oct 21. Crit Rev Oncol Hematol. 2023. PMID: 37871779 Free article.
hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC.
Trono P, Tocci A, Palermo B, Di Carlo A, D'Ambrosio L, D'Andrea D, Di Modugno F, De Nicola F, Goeman F, Corleone G, Warren S, Paolini F, Panetta M, Sperduti I, Baldari S, Visca P, Carpano S, Cappuzzo F, Russo V, Tripodo C, Zucali P, Gregorc V, Marchesi F, Nistico P. Trono P, et al. Among authors: nistico p. J Immunother Cancer. 2023 Aug;11(8):e006913. doi: 10.1136/jitc-2023-006913. J Immunother Cancer. 2023. PMID: 37612043 Free PMC article.
Blood immune cells as potential biomarkers predicting relapse-free survival of stage III/IV resected melanoma patients treated with peptide-based vaccination and interferon-alpha.
Moschella F, Buccione C, Ruspantini I, Castiello L, Rozo Gonzalez A, Iacobone F, Ferraresi V, Palermo B, Nisticò P, Belardelli F, Proietti E, Macchia I, Urbani F. Moschella F, et al. Among authors: nistico p. Front Oncol. 2023 May 18;13:1145667. doi: 10.3389/fonc.2023.1145667. eCollection 2023. Front Oncol. 2023. PMID: 37274275 Free PMC article.
Cancer immunity and immunotherapy beyond COVID-19.
Bellone M, Brevi A, Bronte V, Dusi S, Ferrucci PF, Nisticò P, Rosato A, Russo V, Sica A, Toietta G, Colombo MP. Bellone M, et al. Among authors: nistico p. Cancer Immunol Immunother. 2023 Jul;72(7):2541-2548. doi: 10.1007/s00262-023-03411-9. Epub 2023 Mar 30. Cancer Immunol Immunother. 2023. PMID: 36995489 Free PMC article. No abstract available.
67 results